Lucas G Wiessing
Lucas G Wiessing
EMCDDA
Подтвержден адрес электронной почты в домене emcdda.europa.eu
НазваниеПроцитированоГод
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ...
The Lancet 372 (9651), 1733-1745, 2008
13542008
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
BM Mathers, L Degenhardt, H Ali, L Wiessing, M Hickman, RP Mattick, ...
Lancet 375 (9719), 1014-1028, 2010
724*2010
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
L Sordo, G Barrio, MJ Bravo, BI Indave, L Degenhardt, L Wiessing, M Ferri, ...
bmj 357, j1550, 2017
3222017
Mortality among people who inject drugs: a systematic review and meta-analysis
BM Mathers, L Degenhardt, C Bucello, J Lemon, L Wiessing, M Hickman
Bulletin of the World Health Organization 91, 102-123, 2013
2872013
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference
A Hatzakis, S Wait, J Bruix, M Buti, M Carballo, M Cavaleri, M Colombo, ...
Journal of Viral Hepatitis 18, 1-16, 2011
2772011
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim, M Salminen, ...
BMC infectious diseases 13 (1), 181, 2013
2032013
Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention
L Wiessing, M Ferri, B Grady, M Kantzanou, I Sperle, KJ Cullen, ...
PloS one 9 (7), e103345, 2014
1642014
Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution
C Aceijas, SR Friedman, HLF Cooper, L Wiessing, GV Stimson, ...
Sexually transmitted infections 82 (suppl 3), iii10-iii17, 2006
1562006
Estimating prevalence of problem drug use at national level in countries of the European Union and Norway
L Kraus, R Augustin, M Frischer, P Kümmler, A Uhl, L Wiessing
Addiction 98 (4), 471-485, 2003
1482003
Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature
K Roy, G Hay, R Andragetti, A Taylor, D Goldberg, L Wiessing
Epidemiology & Infection 129 (3), 577-585, 2002
1462002
Meth/amphetamine use and associated HIV: Implications for global policy and public health
L Degenhardt, B Mathers, M Guarinieri, S Panda, B Phillips, SA Strathdee, ...
International Journal of Drug Policy 21 (5), 347-358, 2010
1362010
What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews
L Degenhardt, C Bucello, B Calabria, P Nelson, A Roberts, W Hall, ...
Drug and alcohol dependence 117 (2-3), 85-101, 2011
1192011
The Dutch famine birth cohort study: design, validation of exposure, and selected characteristics of subjects after 43 years follow‐up
LH Lumey, ACJ Ravelli, LG Wiessing, JG Koppe, PE Treffers, ZA Stein
Paediatric and perinatal epidemiology 7 (4), 354-367, 1993
1161993
A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain
M Frischer, M Hickman, L Kraus, F Mariani, L Wiessing
Addiction 96 (10), 1465-1476, 2001
1142001
Modelling the spread of HIV in social networks of injecting drug users
M Kretzschmar, LG Wiessing
Aids 12 (7), 801-811, 1998
981998
Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study
D Paraskevis, G Nikolopoulos, A Fotiou, C Tsiara, D Paraskeva, V Sypsa, ...
PloS one 8 (11), e78941, 2013
852013
Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners
A Kamarulzaman, SE Reid, A Schwitters, L Wiessing, N El-Bassel, ...
The Lancet 388 (10049), 1115-1126, 2016
842016
Can hepatitis C virus prevalence be used as a measure of injection‐related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis
P Vickerman, M Hickman, M May, M Kretzschmar, L Wiessing
Addiction 105 (2), 311-318, 2010
722010
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference
A Hatzakis, P Van Damme, K Alcorn, C Gore, M Benazzouz, S Berkane, ...
Journal of viral hepatitis 20, 1-20, 2013
682013
Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries
J Reimer, B Schulte, X Castells, I Schafer, S Polywka, D Hedrich, ...
Clinical Infectious Diseases 40 (Supplement_5), S373-S378, 2005
662005
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20